The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells

Highlights • The retinoblastoma (Rb) protein modulates the response of human liver cancer cells to sorafenib. • Sorafenib is more cytotoxic in cells with reduced levels of Rb. • Rb knock-down cells exposed to sorafenib encounter ferroptosis, a new form of regulated necrosis. • Rb-negative cancer cel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2015-01, Vol.356 (2), p.971-977
Hauptverfasser: Louandre, Christophe, Marcq, Ingrid, Bouhlal, Hicham, Lachaier, Emma, Godin, Corinne, Saidak, Zuzana, François, Catherine, Chatelain, Denis, Debuysscher, Véronique, Barbare, Jean-Claude, Chauffert, Bruno, Galmiche, Antoine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 977
container_issue 2
container_start_page 971
container_title Cancer letters
container_volume 356
creator Louandre, Christophe
Marcq, Ingrid
Bouhlal, Hicham
Lachaier, Emma
Godin, Corinne
Saidak, Zuzana
François, Catherine
Chatelain, Denis
Debuysscher, Véronique
Barbare, Jean-Claude
Chauffert, Bruno
Galmiche, Antoine
description Highlights • The retinoblastoma (Rb) protein modulates the response of human liver cancer cells to sorafenib. • Sorafenib is more cytotoxic in cells with reduced levels of Rb. • Rb knock-down cells exposed to sorafenib encounter ferroptosis, a new form of regulated necrosis. • Rb-negative cancer cells encounter increased levels of oxidative stress.
doi_str_mv 10.1016/j.canlet.2014.11.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1629996046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0304383514006703</els_id><sourcerecordid>3515913501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-174038d4111fbada1e1c6cfefd82257b1fb61013b6e56730ea73eaebd0ce604a3</originalsourceid><addsrcrecordid>eNqFUV2L1TAUDKK419V_IFLwRR9az0nStH0RZPELFgRdn0OSnrq59jbXJBXuvzflrgq--JKBk5k5zBzGniI0CKhe7RtnlplywwFlg9gUuMd22He87oYe7rMdCJC16EV7wR6ltAeAVnbtQ3bBWynlwPmOxZtbqiJlvwQ7m5TDwVQvPtuX1TGGTH4pf9_W2WRK1UQxhmMOyafKL-PqaKzsqUohmokWb8uwul0Pprx0NDk4mucijZUz0RX_4ryN0mP2YDJzoid3eMm-vnt7c_Whvv70_uPVm-vatYi5xk6C6EeJiJM1o0FCp9xE09hz3na2TFUpQlhFreoEkOkEGbIjOFIgjbhkz8--JcqPlVLW-7DGpazUqPgwDIWlCkueWS6GlCJN-hj9wcSTRtBb0Xqvz0XrrWiNqAsU2bM789UeaPwj-t1sIbw-E6hE_Okp6uQ8LaU0H8llPQb_vw3_GrjZL96Z-TudKP3NohPXoL9sx95ujRJAdSDELy81p5U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629996046</pqid></control><display><type>article</type><title>The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Louandre, Christophe ; Marcq, Ingrid ; Bouhlal, Hicham ; Lachaier, Emma ; Godin, Corinne ; Saidak, Zuzana ; François, Catherine ; Chatelain, Denis ; Debuysscher, Véronique ; Barbare, Jean-Claude ; Chauffert, Bruno ; Galmiche, Antoine</creator><creatorcontrib>Louandre, Christophe ; Marcq, Ingrid ; Bouhlal, Hicham ; Lachaier, Emma ; Godin, Corinne ; Saidak, Zuzana ; François, Catherine ; Chatelain, Denis ; Debuysscher, Véronique ; Barbare, Jean-Claude ; Chauffert, Bruno ; Galmiche, Antoine</creatorcontrib><description>Highlights • The retinoblastoma (Rb) protein modulates the response of human liver cancer cells to sorafenib. • Sorafenib is more cytotoxic in cells with reduced levels of Rb. • Rb knock-down cells exposed to sorafenib encounter ferroptosis, a new form of regulated necrosis. • Rb-negative cancer cells encounter increased levels of oxidative stress.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2014.11.014</identifier><identifier>PMID: 25444922</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Biomedical research ; Blotting, Western ; Carcinoma, Hepatocellular - drug therapy ; Carcinoma, Hepatocellular - metabolism ; Carcinoma, Hepatocellular - pathology ; Cell Proliferation - drug effects ; Cyclin-dependent kinases ; Cytotoxicity ; Female ; Ferroptosis ; Genes ; Hematology, Oncology and Palliative Medicine ; Hepatocellular carcinoma ; Humans ; Kinases ; Liver cancer ; Liver Neoplasms - drug therapy ; Liver Neoplasms - metabolism ; Liver Neoplasms - pathology ; Medical prognosis ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Mitochondria - drug effects ; Mitochondria - metabolism ; Mitochondria - pathology ; Mortality ; Necrosis ; Niacinamide - analogs &amp; derivatives ; Niacinamide - pharmacology ; Oxidative stress ; Oxidative Stress - drug effects ; Phenylurea Compounds - pharmacology ; Proteins ; Reactive Oxygen Species - metabolism ; Retinoblastoma Protein - metabolism ; Rodents ; Sorafenib ; Stress measurement ; Studies ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays</subject><ispartof>Cancer letters, 2015-01, Vol.356 (2), p.971-977</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2014 Elsevier Ireland Ltd</rights><rights>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Jan 28, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-174038d4111fbada1e1c6cfefd82257b1fb61013b6e56730ea73eaebd0ce604a3</citedby><cites>FETCH-LOGICAL-c511t-174038d4111fbada1e1c6cfefd82257b1fb61013b6e56730ea73eaebd0ce604a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304383514006703$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25444922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Louandre, Christophe</creatorcontrib><creatorcontrib>Marcq, Ingrid</creatorcontrib><creatorcontrib>Bouhlal, Hicham</creatorcontrib><creatorcontrib>Lachaier, Emma</creatorcontrib><creatorcontrib>Godin, Corinne</creatorcontrib><creatorcontrib>Saidak, Zuzana</creatorcontrib><creatorcontrib>François, Catherine</creatorcontrib><creatorcontrib>Chatelain, Denis</creatorcontrib><creatorcontrib>Debuysscher, Véronique</creatorcontrib><creatorcontrib>Barbare, Jean-Claude</creatorcontrib><creatorcontrib>Chauffert, Bruno</creatorcontrib><creatorcontrib>Galmiche, Antoine</creatorcontrib><title>The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Highlights • The retinoblastoma (Rb) protein modulates the response of human liver cancer cells to sorafenib. • Sorafenib is more cytotoxic in cells with reduced levels of Rb. • Rb knock-down cells exposed to sorafenib encounter ferroptosis, a new form of regulated necrosis. • Rb-negative cancer cells encounter increased levels of oxidative stress.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biomedical research</subject><subject>Blotting, Western</subject><subject>Carcinoma, Hepatocellular - drug therapy</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Cell Proliferation - drug effects</subject><subject>Cyclin-dependent kinases</subject><subject>Cytotoxicity</subject><subject>Female</subject><subject>Ferroptosis</subject><subject>Genes</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Kinases</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - pathology</subject><subject>Medical prognosis</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Nude</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondria - pathology</subject><subject>Mortality</subject><subject>Necrosis</subject><subject>Niacinamide - analogs &amp; derivatives</subject><subject>Niacinamide - pharmacology</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Phenylurea Compounds - pharmacology</subject><subject>Proteins</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Retinoblastoma Protein - metabolism</subject><subject>Rodents</subject><subject>Sorafenib</subject><subject>Stress measurement</subject><subject>Studies</subject><subject>Tumor Cells, Cultured</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUV2L1TAUDKK419V_IFLwRR9az0nStH0RZPELFgRdn0OSnrq59jbXJBXuvzflrgq--JKBk5k5zBzGniI0CKhe7RtnlplywwFlg9gUuMd22He87oYe7rMdCJC16EV7wR6ltAeAVnbtQ3bBWynlwPmOxZtbqiJlvwQ7m5TDwVQvPtuX1TGGTH4pf9_W2WRK1UQxhmMOyafKL-PqaKzsqUohmokWb8uwul0Pprx0NDk4mucijZUz0RX_4ryN0mP2YDJzoid3eMm-vnt7c_Whvv70_uPVm-vatYi5xk6C6EeJiJM1o0FCp9xE09hz3na2TFUpQlhFreoEkOkEGbIjOFIgjbhkz8--JcqPlVLW-7DGpazUqPgwDIWlCkueWS6GlCJN-hj9wcSTRtBb0Xqvz0XrrWiNqAsU2bM789UeaPwj-t1sIbw-E6hE_Okp6uQ8LaU0H8llPQb_vw3_GrjZL96Z-TudKP3NohPXoL9sx95ujRJAdSDELy81p5U</recordid><startdate>20150128</startdate><enddate>20150128</enddate><creator>Louandre, Christophe</creator><creator>Marcq, Ingrid</creator><creator>Bouhlal, Hicham</creator><creator>Lachaier, Emma</creator><creator>Godin, Corinne</creator><creator>Saidak, Zuzana</creator><creator>François, Catherine</creator><creator>Chatelain, Denis</creator><creator>Debuysscher, Véronique</creator><creator>Barbare, Jean-Claude</creator><creator>Chauffert, Bruno</creator><creator>Galmiche, Antoine</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20150128</creationdate><title>The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells</title><author>Louandre, Christophe ; Marcq, Ingrid ; Bouhlal, Hicham ; Lachaier, Emma ; Godin, Corinne ; Saidak, Zuzana ; François, Catherine ; Chatelain, Denis ; Debuysscher, Véronique ; Barbare, Jean-Claude ; Chauffert, Bruno ; Galmiche, Antoine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-174038d4111fbada1e1c6cfefd82257b1fb61013b6e56730ea73eaebd0ce604a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biomedical research</topic><topic>Blotting, Western</topic><topic>Carcinoma, Hepatocellular - drug therapy</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Cell Proliferation - drug effects</topic><topic>Cyclin-dependent kinases</topic><topic>Cytotoxicity</topic><topic>Female</topic><topic>Ferroptosis</topic><topic>Genes</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Kinases</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - pathology</topic><topic>Medical prognosis</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Nude</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondria - pathology</topic><topic>Mortality</topic><topic>Necrosis</topic><topic>Niacinamide - analogs &amp; derivatives</topic><topic>Niacinamide - pharmacology</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Phenylurea Compounds - pharmacology</topic><topic>Proteins</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Retinoblastoma Protein - metabolism</topic><topic>Rodents</topic><topic>Sorafenib</topic><topic>Stress measurement</topic><topic>Studies</topic><topic>Tumor Cells, Cultured</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Louandre, Christophe</creatorcontrib><creatorcontrib>Marcq, Ingrid</creatorcontrib><creatorcontrib>Bouhlal, Hicham</creatorcontrib><creatorcontrib>Lachaier, Emma</creatorcontrib><creatorcontrib>Godin, Corinne</creatorcontrib><creatorcontrib>Saidak, Zuzana</creatorcontrib><creatorcontrib>François, Catherine</creatorcontrib><creatorcontrib>Chatelain, Denis</creatorcontrib><creatorcontrib>Debuysscher, Véronique</creatorcontrib><creatorcontrib>Barbare, Jean-Claude</creatorcontrib><creatorcontrib>Chauffert, Bruno</creatorcontrib><creatorcontrib>Galmiche, Antoine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Louandre, Christophe</au><au>Marcq, Ingrid</au><au>Bouhlal, Hicham</au><au>Lachaier, Emma</au><au>Godin, Corinne</au><au>Saidak, Zuzana</au><au>François, Catherine</au><au>Chatelain, Denis</au><au>Debuysscher, Véronique</au><au>Barbare, Jean-Claude</au><au>Chauffert, Bruno</au><au>Galmiche, Antoine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2015-01-28</date><risdate>2015</risdate><volume>356</volume><issue>2</issue><spage>971</spage><epage>977</epage><pages>971-977</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Highlights • The retinoblastoma (Rb) protein modulates the response of human liver cancer cells to sorafenib. • Sorafenib is more cytotoxic in cells with reduced levels of Rb. • Rb knock-down cells exposed to sorafenib encounter ferroptosis, a new form of regulated necrosis. • Rb-negative cancer cells encounter increased levels of oxidative stress.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>25444922</pmid><doi>10.1016/j.canlet.2014.11.014</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2015-01, Vol.356 (2), p.971-977
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_journals_1629996046
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antineoplastic Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Biomedical research
Blotting, Western
Carcinoma, Hepatocellular - drug therapy
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
Cell Proliferation - drug effects
Cyclin-dependent kinases
Cytotoxicity
Female
Ferroptosis
Genes
Hematology, Oncology and Palliative Medicine
Hepatocellular carcinoma
Humans
Kinases
Liver cancer
Liver Neoplasms - drug therapy
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Medical prognosis
Mice
Mice, Inbred BALB C
Mice, Nude
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondria - pathology
Mortality
Necrosis
Niacinamide - analogs & derivatives
Niacinamide - pharmacology
Oxidative stress
Oxidative Stress - drug effects
Phenylurea Compounds - pharmacology
Proteins
Reactive Oxygen Species - metabolism
Retinoblastoma Protein - metabolism
Rodents
Sorafenib
Stress measurement
Studies
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
title The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T13%3A16%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20retinoblastoma%20(Rb)%20protein%20regulates%20ferroptosis%20induced%20by%20sorafenib%20in%20human%20hepatocellular%20carcinoma%20cells&rft.jtitle=Cancer%20letters&rft.au=Louandre,%20Christophe&rft.date=2015-01-28&rft.volume=356&rft.issue=2&rft.spage=971&rft.epage=977&rft.pages=971-977&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2014.11.014&rft_dat=%3Cproquest_cross%3E3515913501%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629996046&rft_id=info:pmid/25444922&rft_els_id=1_s2_0_S0304383514006703&rfr_iscdi=true